Regulatory role of miR-211-5p in hepatocellular carcinoma metastasis by targeting ZEB2

Biomed Pharmacother. 2017 Jun:90:806-812. doi: 10.1016/j.biopha.2017.03.081. Epub 2017 Apr 20.

Abstract

Hepatocellular carcinoma (HCC) is the most common type of cancer and the rapid tumor growth, drug resistance and metastasis are the major problems for HCC therapy. MicroRNAs (miRNAs) involve in various cell biological processes in HCC. ZEB2 plays crucial roles in HCC progression. ZEB2 is regulated by some identified miRNAs, but there needs to find new miRNAs regulating ZEB2 expression for better understanding the molecular mechanism of HCC. In the present study, ZEB2 was identified as a direct target of miR-211-5p, which was a potential oncogene in cancer. We found that miR-211-5p levels in HCC tissues were lower than the compared normal tissues. ZEB2 expression was higher in HCC tissues and was negatively related to miR-211-5p levels. Overexpression of miR-211-5p in human HCC cell lines (HepG2 and 7721) caused the delay of cell proliferation, apoptosis and drug sensitivity. Summarily, our study demonstrates that miR-211-5p may play a suppressing role in HCC by inhibiting ZEB2 expression.

Keywords: Hepatocellular carcinoma; ZEB2; miR-211-5p.

MeSH terms

  • Apoptosis / genetics
  • Carcinoma, Hepatocellular / genetics*
  • Carcinoma, Hepatocellular / pathology
  • Cell Line, Tumor
  • Cell Proliferation / genetics
  • Disease Progression
  • Gene Expression Regulation, Neoplastic / genetics
  • Hep G2 Cells
  • Humans
  • Liver Neoplasms / genetics*
  • Liver Neoplasms / pathology
  • MicroRNAs / genetics*
  • Zinc Finger E-box Binding Homeobox 2 / genetics*

Substances

  • MIRN211 microRNA, human
  • MicroRNAs
  • ZEB2 protein, human
  • Zinc Finger E-box Binding Homeobox 2